HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
复制标题
结膜黑素细胞病变的 HMB-45 免疫组织化学染色。
DOI:
10.1016/s0161-6420(91)32281-4
复制
发表时间:
1991
期刊:
影响因子:
13.7
通讯作者:
Wagner,D
中科院分区:
文献类型:
--
作者:
McDonnell,JM;Sun,YY;Wagner,D
HMB-45 is a monoclonal antibody recently described as being highly specific for melanocytic proliferations of the skin and in metastases of melanotic lesions. To determine a possible role for HMB-45 in ophthalmic pathology, 45 conjunctival lesions, including 23 melanomas, were analyzed using immunohistochemical techniques with anti-S-100 and HMB-45 as primary antibodies. Nineteen (82.6%) of the melanomas exhibited HMB-45 positivity, and 19 (82.6%) contained S-100 protein, with concordance of all but two cases. Seven cases of primary acquired melanosis were studied: one (33%) of three with atypia was HMB-45 positive, as were two (50%) of four without atypia. Among nevi, 1(9.1%) of 11 showed faint staining with HMB-45. Fifteen conjunctival epithelial dysplasias were negative with HMB-45. At present, HMB-45 appears to offer no great advantage over S-100 protein in the analysis of conjunctival melanomas. Its role in the distinction of benign from atypical or malignant junctional melanocytic proliferations remains unclear.